创伤内皮病时内皮微囊泡无变化
本研究为前瞻性观察性研究,纳入严重创伤患者,按Syndecan-1水平将12例EOT患者与12例低水平患者按损伤严重度评分(ISS)、简明损伤定级和年龄匹配。入院时采血检测血栓弹力图及细胞损伤相关生物标志物,用流式细胞术以多种内皮相关单克隆抗体检测内皮微囊泡(EMVs)。结果显示两组入院生理和ISS(29 vs. 28)相似,EOT组Syndecan-1为230(158, 293)vs. 19(14, 25)ng/mL、肾上腺素和可溶性血栓调节蛋白更高,血栓弹力图示凝血启动、放大、传播和强度降低,输血频率92% vs. 33%;但无论使用何种抗体,EMVs均无差异,去甲肾上腺素、sE-selectin、sVE-cadherin和组蛋白复合DNA片段水平相似。结论认为,在表现为EOT的创伤患者中,基于EMVs及其他生物标志物未升高,似乎未发生内皮细胞损伤或凋亡,提示内皮糖萼破坏是EOT的潜在主要原因。
要点
- 严重创伤EOT患者(Syndecan-1升高)与匹配的低水平患者相比,入院时EMVs无论用何种抗体检测均无差异。
- EOT组Syndecan-1为230(158, 293)vs. 19(14, 25)ng/mL,肾上腺素和可溶性血栓调节蛋白水平更高。
- EOT组血栓弹力图示凝血启动、放大、传播和强度降低,输血频率92% vs. 33%。
- 去甲肾上腺素、sE-selectin、sVE-cadherin和组蛋白复合DNA片段水平两组相似。
- 作者认为EOT似乎并非由内皮细胞损伤或凋亡所致,内皮糖萼破坏可能是EOT的潜在主要原因。
适用人群与场景
- 前瞻性观察性研究纳入的严重创伤患者,按Syndecan-1水平分为EOT组12例与低水平组12例,按ISS、简明损伤定级和年龄匹配。
诊断标准与关键阈值
- EOT判定基于Syndecan-1水平升高;两组匹配依据为损伤严重度评分(ISS)、简明损伤定级和年龄。
研究设计与关键结果
- 前瞻性观察性研究,12例EOT患者与12例低Syndecan-1水平患者按ISS、简明损伤定级和年龄匹配。
- 两组入院生理和ISS(29 vs. 28)相似。
- EOT组Syndecan-1为230(158, 293)vs. 19(14, 25)ng/mL,肾上腺素和可溶性血栓调节蛋白水平更高。
- EOT组血栓弹力图示凝血启动、放大、传播和强度降低,输血频率92% vs. 33%。
- 无论使用何种抗体,EMVs均无差异;去甲肾上腺素、sE-selectin、sVE-cadherin和组蛋白复合DNA片段水平相似。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在表现为EOT的创伤患者中,内皮细胞损伤或凋亡似乎未发生,内皮糖萼破坏可能是EOT的潜在主要原因。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Severe trauma is accompanied by endothelial glycocalyx disruption, which drives coagulopathy, increasing transfusion requirements and death. This syndrome has been termed endotheliopathy of trauma (EOT). Some have suggested EOT results from endothelial cellular damage and apoptosis. Endothelial microvesicles (EMVs) represent cellular damage. We hypothesized that EOT is associated with endothelial damage and apoptosis resulting in an increase in circulating EMVs.
METHODS: Prospective, observational study enrolling severely injured patients. Twelve patients with EOT, based on elevated Syndecan-1 levels, were matched with 12 patients with lower levels, based on Injury Severity Score (ISS), abbreviated injury scale profile, and age. Thrombelastography and plasma levels of biomarkers indicative of cellular damage were measured from blood samples collected on admission. EMVs were determined by flow cytometry using varied monoclonal antibodies associated with endothelial cells. Significance was set at P < 0.05.
RESULTS: Admission physiology and ISS (29 vs. 28) were similar between groups. Patients with EOT had higher Syndecan-1, 230 (158, 293) vs. 19 (14, 25) ng/mL, epinephrine, and soluble thrombomodulin levels. Based on thrombelastography, EOT had reductions in clot initiation, amplification, propagation and strength, and a greater frequency of transfusion, 92% vs. 33%. There were no differences in EMVs irrespective of the antibody used. Plasma norepinephrine, sE-selectin, sVE-cadherin, and histone-complexed DNA fragments levels were similar.
CONCLUSION: In trauma patients presenting with EOT, endothelial cellular damage or apoptosis does not seem to occur based on the absence of an increase in EMVs and other biomarkers. Thus, this suggests endothelial glycocalyx disruption is the underlying primary cause of EOT.
参考来源
- Wade CE, Matijevic N, Wang YW, et al. Absences of Endothelial Microvesicle Changes in the Presence of the Endotheliopathy of Trauma. Shock. 2019. PMID: 29621120. doi:10.1097/SHK.0000000000001149
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。